Browse Data and Analysis

This is a regional report on West Africa that primarily covers Senegal, Burkina Faso, and Mali, but also provides brief overviews in certain sections for Niger, The Gambia, Guinea, Guinea-Bissau, and Mauritania.

Kazakhstan has not announced any changes to its biotechnology policies. Major challenges like climate change, variable weather, monocropping wheat, and the reliance on Eurasian Economic Union (EAEU) member biotechnology regulations could be a future catalyst for Kazakhstan to develop its own biotechnology law.

This is a regional report on West Africa that primarily covers Senegal, Burkina Faso, and Mali, but also provides brief overviews in certain sections for Niger, The Gambia, Guinea, Guinea-Bissau, and Mauritania.

Kazakhstan has not announced any changes to its biotechnology policies. Major challenges like climate change, variable weather, monocropping wheat, and the reliance on Eurasian Economic Union (EAEU) member biotechnology regulations could be a future catalyst for Kazakhstan to develop its own biotechnology law.

In the past year, there have been no major changes in Kazakhstan’s biotechnology policies, although the government may be making plans to regulate and commercialize agricultural biotechnologies. For the time being, Kazakhstan continues to rely on Eurasian Economic Union (EAEU) regulations for guidance on biotechnology issues.

This is a regional report on West Africa that primarily covers Senegal, Burkina Faso, and Mali, but also provides brief overviews in certain sections for Niger, The Gambia, Guinea, Guinea-Bissau, and Mauritania. Senegal and Mauritania passed new biosafety laws on June 14, 2022, and August 4, 2022, respectively.

The Government of Senegal is reviewing and revising its new biosafety law which may include language for an expedited approval process for certain genetically engineered (GE) products.

In the past year, there have been no major changes in Kazakhstan’s biotechnology policy.

The Government of Senegal is reviewing and revising its new biosafety law which may include language for an expedited approval process for certain genetically engineered (GE) products.

In October 2019, the Government of Niger promulgated National Biosafety Law 2019-48 which applies to genetically engineered products developed domestically or by a third country.

The Biosafety Law, 2012 contains information on the biotechnology approval process in Burkina Faso for genetically engineered (GE) products developed domestically or by a third country.

In the past year, there have been no major changes in Kazakhstan’s biotechnology policy.